Salus Biopharma

Salus Biopharma is an Italian specialty pharmaceutical company that focuses on the development and commercialization of products in therapeutic areas such as urology, gynecology, gastroenterology, and respiratory health. Acquired by IBSA Farmaceutici in 2011, the company operates as a specialized division within the IBSA Group, leveraging innovative delivery technologies like orodispersible films. Its portfolio includes a mix of prescription pharmaceuticals, medical devices, and high-end nutraceuticals designed to improve patient quality of life. Key products include Siler for erectile dysfunction and the Kistinox line for urinary tract health. The company is headquartered in Rome and maintains a significant presence in the Italian primary care and specialist markets through a dedicated sales force.